{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T00:53:52Z","timestamp":1767142432206,"version":"build-2238731810"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T00:00:00Z","timestamp":1618185600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1007\/s12149-021-01614-7","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T04:03:51Z","timestamp":1618200231000},"page":"728-734","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["In vivo detection of beta-amyloid at the nasal cavity and other skull-base sites: a retrospective evaluation of ADNI1\/GO"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8779-1962","authenticated-orcid":false,"given":"Anish","family":"Kapadia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prarthana","family":"Desai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Dmytriw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pejman","family":"Maralani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Heyn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Black","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Symons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"For the Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,12]]},"reference":[{"issue":"9","key":"1614_CR1","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1016\/S1474-4422(11)70072-2","volume":"10","author":"DE Barnes","year":"2011","unstructured":"Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer\u2019s disease prevalence. Lancet Neurol. 2011;10(9):819\u201328. https:\/\/doi.org\/10.1016\/S1474-4422(11)70072-2.","journal-title":"Lancet Neurol"},{"issue":"2","key":"1614_CR2","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s00401-017-1717-7","volume":"134","author":"A Kapasi","year":"2017","unstructured":"Kapasi A, DeCarli C, Schneider JA. Impact of multiple pathologies on the threshold for clinically overt dementia. Acta Neuropathol. 2017;134(2):171\u201386. https:\/\/doi.org\/10.1007\/s00401-017-1717-7.","journal-title":"Acta Neuropathol"},{"key":"1614_CR3","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-016-0303-5","author":"NY Kirson","year":"2016","unstructured":"Kirson NY, Desai U, Ristovska L, et al. Assessing the economic burden of Alzheimer\u2019s disease patients first diagnosed by specialists. BMC Geriatr. 2016. https:\/\/doi.org\/10.1186\/s12877-016-0303-5.","journal-title":"BMC Geriatr."},{"key":"1614_CR4","unstructured":"G8 Dementia Summit Declaration 2013. Accessed January 11, 2020. http:\/\/www.g8.utoronto.ca\/healthG8\/2013-dementia-declaration.html."},{"key":"1614_CR5","doi-asserted-by":"publisher","DOI":"10.1111\/neup.12626","author":"R Sengoku","year":"2020","unstructured":"Sengoku R. Aging and Alzheimer\u2019s disease pathology. Neuropathology. 2020. https:\/\/doi.org\/10.1111\/neup.12626.","journal-title":"Neuropathology"},{"issue":"4","key":"1614_CR6","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.3233\/JAD-140843","volume":"42","author":"C-C Tan","year":"2014","unstructured":"Tan C-C, Yu J-T, Tan L. Biomarkers for preclinical Alzheimer\u2019s disease. J Alzheimer\u2019s Dis. 2014;42(4):1051\u201369. https:\/\/doi.org\/10.3233\/JAD-140843.","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"6012","key":"1614_CR7","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1126\/science.1197623","volume":"330","author":"KG Mawuenyega","year":"2010","unstructured":"Mawuenyega KG, Sigurdson W, Ovod V, et al. Decreased clearance of CNS \u03b2-amyloid in Alzheimer\u2019s disease. Science. 2010;330(6012):1774\u20131774. https:\/\/doi.org\/10.1126\/science.1197623.","journal-title":"Science"},{"issue":"3","key":"1614_CR8","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1007\/s12640-018-9895-1","volume":"34","author":"S-H Xin","year":"2018","unstructured":"Xin S-H, Tan L, Cao X, Yu J-T, Tan L. Clearance of amyloid beta and tau in Alzheimer\u2019s disease: from mechanisms to therapy. Neurotox Res. 2018;34(3):733\u201348. https:\/\/doi.org\/10.1007\/s12640-018-9895-1.","journal-title":"Neurotox Res"},{"issue":"1","key":"1614_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1743-8454-1-2","volume":"1","author":"M Johnston","year":"2004","unstructured":"Johnston M, Zakharov A, Papaiconomou C, Salmasi G, Armstrong D. Evidence of connections between cerebrospinal fluid and nasal lymphatic vessels in humans, non-human primates and other mammalian species. Fluids Barriers CNS. 2004;1(1):1\u201313. https:\/\/doi.org\/10.1186\/1743-8454-1-2.","journal-title":"Fluids Barriers CNS"},{"issue":"1","key":"1614_CR10","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1089\/15396850360495682","volume":"1","author":"M Johnston","year":"2003","unstructured":"Johnston M. The importance of lymphatics in cerebrospinal fluid transport. Lymphat Res Biol. 2003;1(1):41\u20135. https:\/\/doi.org\/10.1089\/15396850360495682.","journal-title":"Lymphat Res Biol"},{"issue":"7560","key":"1614_CR11","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature14432","volume":"523","author":"A Louveau","year":"2015","unstructured":"Louveau A, Smirnov I, Keyes TJ, et al. Structural and functional features of central nervous system lymphatic vessels. Nature. 2015;523(7560):337\u201341. https:\/\/doi.org\/10.1038\/nature14432.","journal-title":"Nature"},{"key":"1614_CR12","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.nbd.2014.07.012","volume":"71","author":"M Pappolla","year":"2014","unstructured":"Pappolla M, Sambamurti K, Vidal R, Pacheco-Quinto J, Poeggeler B, Matsubara E. Evidence for lymphatic A\u03b2 clearance in Alzheimer\u2019s transgenic mice. Neurobiol Dis. 2014;71:215\u20139. https:\/\/doi.org\/10.1016\/j.nbd.2014.07.012.","journal-title":"Neurobiol Dis"},{"issue":"9","key":"1614_CR13","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","volume":"58","author":"MJ de Leon","year":"2017","unstructured":"de Leon MJ, Li Y, Okamura N, et al. Cerebrospinal fluid clearance in Alzheimer disease measured with dynamic PET. J Nucl Med. 2017;58(9):1471\u20136. https:\/\/doi.org\/10.2967\/jnumed.116.187211.","journal-title":"J Nucl Med"},{"key":"1614_CR14","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1007\/s00401-012-1025-1","volume":"124","author":"I Driscoll","year":"2012","unstructured":"Driscoll I, Troncoso JC, Rudow GL, et al. Correspondence between in vivo 11C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques. Acta Neuropathol. 2012;124:823\u201331. https:\/\/doi.org\/10.1007\/s00401-012-1025-1.","journal-title":"Acta Neuropathol"},{"issue":"7","key":"1614_CR15","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1212\/wnl.34.7.939","volume":"34","author":"G McKhann","year":"1984","unstructured":"McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer\u2019s Disease. Neurology. 1984;34(7):939\u201344. https:\/\/doi.org\/10.1212\/wnl.34.7.939.","journal-title":"Neurology"},{"issue":"12","key":"1614_CR16","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1001\/archneur.58.12.1985","volume":"58","author":"RC Petersen","year":"2001","unstructured":"Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitive impairment. Arch Neurol. 2001;58(12):1985\u201392. https:\/\/doi.org\/10.1001\/archneur.58.12.1985.","journal-title":"Arch Neurol"},{"issue":"3","key":"1614_CR17","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jalz.2010.03.007","volume":"6","author":"MW Weiner","year":"2010","unstructured":"Weiner MW, Aisen PS, Jack CR, et al. The Alzheimer\u2019s disease neuroimaging initiative: progress report and future plans. Alzheimer\u2019s Dementia. 2010;6(3):202-211.e7. https:\/\/doi.org\/10.1016\/j.jalz.2010.03.007.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"15","key":"1614_CR18","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1212\/WNL.0b013e3181bc010c","volume":"73","author":"WJ Jagust","year":"2009","unstructured":"Jagust WJ, Landau SM, Shaw LM, et al. Relationships between biomarkers in aging and dementia. Neurology. 2009;73(15):1193\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3181bc010c.","journal-title":"Neurology"},{"issue":"3","key":"1614_CR19","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.jalz.2010.03.003","volume":"6","author":"WJ Jagust","year":"2010","unstructured":"Jagust WJ, Bandy D, Chen K, et al. The Alzheimer\u2019s disease neuroimaging initiative positron emission tomography core. Alzheimer\u2019s Dementia. 2010;6(3):221\u20139. https:\/\/doi.org\/10.1016\/j.jalz.2010.03.003.","journal-title":"Alzheimer\u2019s Dementia"},{"issue":"1","key":"1614_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11682-011-9136-1","volume":"6","author":"S Swaminathan","year":"2012","unstructured":"Swaminathan S, Shen L, Risacher SL, et al. Amyloid pathway-based candidate gene analysis of [11C]PiB-PET in the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) cohort. Brain Imaging Behav. 2012;6(1):1\u201315. https:\/\/doi.org\/10.1007\/s11682-011-9136-1.","journal-title":"Brain Imaging Behav"},{"issue":"5","key":"1614_CR21","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/S1474-4422(11)70077-1","volume":"10","author":"H Barthel","year":"2011","unstructured":"Barthel H, Gertz H-J, Dresel S, et al. Cerebral amyloid-\u03b2 PET with florbetaben (18F) in patients with Alzheimer\u2019s disease and healthy controls: a multicentre phase 2 diagnostic study. Lancet Neurol. 2011;10(5):424\u201335. https:\/\/doi.org\/10.1016\/S1474-4422(11)70077-1.","journal-title":"Lancet Neurol"},{"key":"1614_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.01.013","author":"S Schindler","year":"2018","unstructured":"Schindler S, Gray J, Gordon B, et al. Cerebrospinal fluid biomarkers measured by Elecsys assays compared to amyloid imaging. Alzheimer\u2019s Dementia. 2018. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.013.","journal-title":"Alzheimer\u2019s Dementia"},{"key":"1614_CR23","doi-asserted-by":"publisher","first-page":"226ra30","DOI":"10.1126\/scitranslmed.3007901","volume":"6","author":"A Fagan","year":"2014","unstructured":"Fagan A, Xiong C, Jasielec M, et al. Longitudinal change in CSF biomarkers in Autosomal-dominant Alzheimer\u2019s disease. Sci Transl Med. 2014;6:226ra30. https:\/\/doi.org\/10.1126\/scitranslmed.3007901.","journal-title":"Sci Transl Med"},{"issue":"1","key":"1614_CR24","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neulet.2007.03.064","volume":"419","author":"K Blennow","year":"2007","unstructured":"Blennow K, Zetterberg H, Minthon L, et al. Longitudinal stability of CSF biomarkers in Alzheimer\u2019s disease. Neurosci Lett. 2007;419(1):18\u201322. https:\/\/doi.org\/10.1016\/j.neulet.2007.03.064.","journal-title":"Neurosci Lett"},{"issue":"4","key":"1614_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.21610","volume":"65","author":"LM Shaw","year":"2009","unstructured":"Shaw LM, Vanderstichele H, Knapik-Czajka M, et al. Cerebrospinal fluid biomarker signature in Alzheimer\u2019s disease neuroimaging initiative subjects. Ann Neurol. 2009;65(4):403\u201313. https:\/\/doi.org\/10.1002\/ana.21610.","journal-title":"Ann Neurol"},{"key":"1614_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-00950-w","author":"A Sala","year":"2020","unstructured":"Sala A, Nordberg A, Rodriguez-Vieitez E. Longitudinal pathways of cerebrospinal fluid and positron emission tomography biomarkers of amyloid-\u03b2 positivity. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-020-00950-w.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"1614_CR27","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1046\/j.1365-2990.1999.00208.x","volume":"25","author":"T Kov\u00e1cs","year":"1999","unstructured":"Kov\u00e1cs T, Cairns NJ, Lantos PL. \u03b2-amyloid deposition and neurofibrillary tangle formation in the olfactory bulb in ageing and Alzheimer\u2019s disease. Neuropathol Appl Neurobiol. 1999;25(6):481\u201391. https:\/\/doi.org\/10.1046\/j.1365-2990.1999.00208.x.","journal-title":"Neuropathol Appl Neurobiol"},{"issue":"5","key":"1614_CR28","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00276-019-02208-9","volume":"41","author":"S Tsutsumi","year":"2019","unstructured":"Tsutsumi S, Ono H, Ishii H, Yasumoto Y. An undescribed venous pathway intervening between the olfactory fossa and nasal vestibule. Surg Radiol Anat. 2019;41(5):485\u201390. https:\/\/doi.org\/10.1007\/s00276-019-02208-9.","journal-title":"Surg Radiol Anat"},{"issue":"13","key":"1614_CR29","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1016\/s0024-3205(01)01232-2","volume":"69","author":"WE Klunk","year":"2001","unstructured":"Klunk WE, Wang Y, Huang GF, Debnath ML, Holt DP, Mathis CA. Uncharged thioflavin-T derivatives bind to amyloid-beta protein with high affinity and readily enter the brain. Life Sci. 2001;69(13):1471\u201384. https:\/\/doi.org\/10.1016\/s0024-3205(01)01232-2.","journal-title":"Life Sci"},{"issue":"46","key":"1614_CR30","doi-asserted-by":"publisher","first-page":"10598","DOI":"10.1523\/JNEUROSCI.2990-05.2005","volume":"25","author":"WE Klunk","year":"2005","unstructured":"Klunk WE, Lopresti BJ, Ikonomovic MD, et al. Binding of the positron emission tomography tracer pittsburgh compound-B Reflects the Amount of amyloid-\u03b2 in Alzheimer\u2019s disease brain but not in transgenic mouse brain. J Neurosci. 2005;25(46):10598\u2013606. https:\/\/doi.org\/10.1523\/JNEUROSCI.2990-05.2005.","journal-title":"J Neurosci"},{"issue":"3","key":"1614_CR31","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/s0960-894x(01)00734-x","volume":"12","author":"CA Mathis","year":"2002","unstructured":"Mathis CA, Bacskai BJ, Kajdasz ST, et al. A lipophilic thioflavin-T derivative for positron emission tomography (PET) imaging of amyloid in brain. Bioorg Med Chem Lett. 2002;12(3):295\u20138. https:\/\/doi.org\/10.1016\/s0960-894x(01)00734-x.","journal-title":"Bioorg Med Chem Lett"},{"issue":"39","key":"1614_CR32","doi-asserted-by":"publisher","first-page":"10365","DOI":"10.1523\/JNEUROSCI.0630-07.2007","volume":"27","author":"MT Fodero-Tavoletti","year":"2007","unstructured":"Fodero-Tavoletti MT, Smith DP, McLean CA, et al. In vitro characterization of Pittsburgh compound-B binding to lewy bodies. J Neurosci. 2007;27(39):10365\u201371. https:\/\/doi.org\/10.1523\/JNEUROSCI.0630-07.2007.","journal-title":"J Neurosci"},{"issue":"3","key":"1614_CR33","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.neures.2013.03.016","volume":"76","author":"N Kameshima","year":"2013","unstructured":"Kameshima N, Yanagisawa D, Tooyama I. \u03b2-Amyloid peptide (1\u201340) in the brain reaches the nasal cavity via a non-blood pathway. Neurosci Res. 2013;76(3):169\u201372. https:\/\/doi.org\/10.1016\/j.neures.2013.03.016.","journal-title":"Neurosci Res"},{"issue":"2","key":"1614_CR34","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neulet.2012.02.026","volume":"513","author":"N Kameshima","year":"2012","unstructured":"Kameshima N, Nanjou T, Fukuhara T, Yanagisawa D, Tooyama I. Correlation of A\u03b2 deposition in the nasal cavity with the formation of senile plaques in the brain of a transgenic mouse model of Alzheimer\u2019s disease. Neurosci Lett. 2012;513(2):166\u20139. https:\/\/doi.org\/10.1016\/j.neulet.2012.02.026.","journal-title":"Neurosci Lett"},{"issue":"2","key":"1614_CR35","doi-asserted-by":"publisher","first-page":"737","DOI":"10.3233\/JAD-170962","volume":"62","author":"Z Liu","year":"2018","unstructured":"Liu Z, Kameshima N, Nanjo T, et al. Development of a high-sensitivity method for the measurement of human nasal A\u03b242, tau, and phosphorylated tau. J Alzheimers Dis. 2018;62(2):737\u201344. https:\/\/doi.org\/10.3233\/JAD-170962.","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"1614_CR36","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-019-41429-1","volume":"9","author":"YH Kim","year":"2019","unstructured":"Kim YH, Lee S-M, Cho S, et al. Amyloid beta in nasal secretions may be a potential biomarker of Alzheimer\u2019s disease. Sci Rep. 2019;9(1):1\u20139. https:\/\/doi.org\/10.1038\/s41598-019-41429-1.","journal-title":"Sci Rep"},{"issue":"4","key":"1614_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","volume":"45","author":"NJ Abbott","year":"2004","unstructured":"Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int. 2004;45(4):545\u201352. https:\/\/doi.org\/10.1016\/j.neuint.2003.11.006.","journal-title":"Neurochem Int"},{"issue":"147","key":"1614_CR38","doi-asserted-by":"publisher","first-page":"147ra111","DOI":"10.1126\/scitranslmed.3003748","volume":"4","author":"JJ Iliff","year":"2012","unstructured":"Iliff JJ, Wang M, Liao Y, et al. A Paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med. 2012;4(147):147ra111-147ra111. https:\/\/doi.org\/10.1126\/scitranslmed.3003748.","journal-title":"Sci Transl Med"},{"issue":"15","key":"1614_CR39","doi-asserted-by":"publisher","first-page":"e1580","DOI":"10.1212\/WNL.0000000000009240","volume":"94","author":"JD Doecke","year":"2020","unstructured":"Doecke JD, P\u00e9rez-Grijalba V, Fandos N, et al. Total A\u03b242\/A\u03b240 ratio in plasma predicts amyloid-PET status, independent of clinical AD diagnosis. Neurology. 2020;94(15):e1580\u201391. https:\/\/doi.org\/10.1212\/WNL.0000000000009240.","journal-title":"Neurology"},{"issue":"6","key":"1614_CR40","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1001\/archneur.56.6.673","volume":"56","author":"N Andreasen","year":"1999","unstructured":"Andreasen N, Hesse C, Davidsson P, et al. Cerebrospinal fluid beta-amyloid(1\u201342) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch Neurol. 1999;56(6):673\u201380. https:\/\/doi.org\/10.1001\/archneur.56.6.673.","journal-title":"Arch Neurol"}],"updated-by":[{"DOI":"10.1007\/s12149-021-01636-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,5,26]],"date-time":"2021-05-26T00:00:00Z","timestamp":1621987200000}}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12149-021-01614-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-021-01614-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,30]],"date-time":"2021-07-30T21:06:28Z","timestamp":1627679188000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12149-021-01614-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,12]]},"references-count":40,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["1614"],"URL":"https:\/\/doi.org\/10.1007\/s12149-021-01614-7","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,12]]},"assertion":[{"value":"15 February 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12149-021-01636-1","URL":"https:\/\/doi.org\/10.1007\/s12149-021-01636-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"There are no financial disclosures from any of the authors related to this manuscript. None of the authors have competing interests with regards to this manuscript.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Ethical approval was obtained at individual sites as per the ADNI protocol highlighter on this ADNI webpage. This included patient consent to participate in the research study and patient consent to publish the data\/results.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}